We have recently shown that up to 70% of melanomas, regardless of whether they possess mutated or wild type BRAF, show hyper-activation of ERBB3 [3] and rely on an ERBB3/ERBB2 signaling cascade to promote cell survival [2]. Here, ERBB2 is linked to melanoma.